Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Chondroitin and Omega-3 are closely matched across evidence, studies, and safety.
Verdict
Probably helps
8 of 13 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
18 of 27 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Chondroitin and Omega-3 have evidence — compare verdict strength side-by-side.
800-1200mg
With meals, Once daily or split into 2-3 doses
Chondroitin sulfate from bovine or marine sources
2-3g combined EPA+DHA daily
With meals containing fat
Triglyceride form fish oil
8-12 weeks
12+ weeks
6-24 months
4-8 weeks
2-4 weeks
Immediate
4-12 weeks
Meta-analysis: chondroitin for osteoarthritis of the knee or hip
Annals of internal medicine (2007) · Meta analysis · n=3846
Large-scale, methodologically sound trials indicate that the symptomatic benefit of chondroitin is minimal or nonexistent.
The Safety and Efficacy of Glucosamine and/or Chondroitin in Humans: A Systematic Review
Nutrients (2025) · Systematic review · n=146
Of the 2013 articles screened, 146 studies were included in our review, with nearly 60% being randomized controlled trials and most conducted in Europe, Asia, or the U.S.
Systematic review and network meta-analysis on the efficacy and safety of parmacotherapy for hand osteoarthritis
PloS one (2024) · Meta analysis · n=3965
GCSB-5, a specific herbal complex that mainly regulate pain in hand osteoarthritis, showed the greatest reduction in pain [WMD = -13.00, 95% CI (-26.69, 0.69)].
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
The New England journal of medicine (2019) · Rct · n=25871
During a median follow-up of 5.3 years, a major cardiovascular event occurred in 386 participants in the n-3 group and in 419 in the placebo group (hazard ratio, 0.92; 95% confidence interval [CI], 0.80 to 1.06; P=0.24).
Omega-3 fatty acids for intermittent claudication
The Cochrane database of systematic reviews (2024) · Meta analysis · n=1830
Omega-3 compared with a control may have little to no effect on ankle-brachial index (MD -0.02, 95% CI -0.08 to 0.04; 3 studies, 168 participants; very low-certainty evidence).
A systematic review and meta-analysis of the omega-3 fatty acids effects on brain-derived neurotrophic factor (BDNF)
Nutritional neuroscience (2024) · Meta analysis · n=587
The present systematic review and meta-analysis indicate the efficacy of omega-3 FAs in increasing the serum concentration of BDNF.
Large meta-analyses show minimal to nonexistent benefits. Effects appear modest at best, with significant study heterogeneity. Combination with glucosamine may be more effective than chondroitin alone.
Based on multiple meta-analyses showing EPA-dominant formulas >1g/day most effective. Effects plateau around 2-2.5g. Adjunctive use with antidepressants shows better outcomes than monotherapy.
AI-estimated from published studies. Interpret as directional guidance.
Both Chondroitin and Omega-3 are closely matched — the best choice depends on your specific health goals.
For reduce inflammation, Omega-3 has a higher relevance score (90 vs 80).
No known interactions between Chondroitin and Omega-3 have been documented in our database. However, always consult a healthcare provider before combining supplements.